Napsin A Antibody (Immunohistochemistry)

The Napsin A Antibody is a highly specific IHC marker. It helps identify
lung adenocarcinoma and clearly separates it from other pulmonary and metastatic tumors.
Moreover, Napsin A is a 38 kDa lysosomal aspartic proteinase expressed in type II pneumocytes and renal tubular cells.

In addition, the combined use of Napsin A and TTF-1 improves diagnostic accuracy.
Therefore, this combination is widely used as a gold-standard approach for confirming primary lung adenocarcinoma.

🔬 Features and Benefits Napsin A Antibody

• Helps diagnose lung adenocarcinoma with high specificity
• Shows clear brown cytoplasmic staining in positive cells
• Works together with TTF-1 to increase diagnostic confidence
• Follows standard IHC protocols in pathology laboratories
• Remains stable for up to 18 months at 2–8 °C

💡 Diagnostic Applications

• Detection of lung adenocarcinoma
• Distinguishing primary tumors from metastatic lesions
• Research studies in epithelial and renal tumor pathology

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the exclusive representative of
Talent Biomedical in Iran, supplies high-quality IHC antibodies, including Napsin A.
In addition, the company focuses on precision, reliability, and global diagnostic standards to support molecular pathology and cancer research across Iran.

“Download Brochure”